MedTrace Logo

The "Step4Life" Randomized Control Trial in Hemodialysis

NCT05241171 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2022-02-15

No results posted yet for this study

Summary

Persons with end-stage kidney disease (ESKD) have very low physical activity, and among ESKD patients, the level of inactivity is strongly associated with morbidity and mortality. This study aimed to assess the feasibility and effectiveness of a 12-week intervention coupling use of wearable pedometers (FitBit ®) and feedback coaching to increase physical activity in hemodialysis patients.

Conditions

Interventions

DEVICE

Fitbit

The study participants in intervention group received feedback based on steps achieved every week (converted to average steps per day) after randomization.

Sponsors & Collaborators

Principal Investigators

  • Rakesh Malhotra, MD, MPH · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-04-30
Completion
2020-05-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241171 on ClinicalTrials.gov